2McDermott DH, Yang Q, Kathiresan S, et ah CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study[J]. Circulation, 2005, 112 (8) : 1113-1120.
3Saederup N, Chan L, Lira SA, et al. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2^-/- mice: evidence for independent chemokine functions in atherogenesis[J]. Circulation, 2008,117 (13) : 1642-1648.
4Tsou CL, Peters W, Si Y, et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites [J]. J Clin Invest, 2007,117 (4) :902-909.
5Kitamoto S, Egashira K. Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases [J]. Expert Rev Cardiovasc Ther,2003,1(3) :393-400.
6Han KH,Chang MK, Boullier A, et al. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator activated receptorγ[J]. J Clin Invest, 2000,106(6) : 793-802.
7Combadiere C, Potteaux S, Rodero M, et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C (hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice [J]. Circulation, 2008,117 ( 13 ) : 1649-1657.
8Tacke F, Alvarez D, Kaplan TJ, et al. Monocyte subsets differentially employ CCR2,CCR5,and CX3CR1 to accumulate within atherosclerotic plaques[J]. J Clin Invest, 2007,117 (1) 185-194.
9Lesnik P, Haskell CA, Charo IF. Decreased atherosclerosis in CX3CR1^-/- mice reveals a role for fractalkine in atherogenesis [J]. J Clin Invest, 2003,111 (3) :333-340.
10Teupser D, Pavlides S, Tan M, et al. Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root[J]. PNAS, 2004,101 (51) : 17795-17800.
4Leinonen M,Saikku P.Infections and atherosclerosis[J].Scand Cardiovasc J,2000,34(1):12-20.
5Kiechl S,Egger G,May M,et al.Chronic infections and the risk of carotid atherosclerosis:prospective results from a large population study[J].Circulation,2001,103(8):1064-1070.
6Hernandez-Presa MA,Bustos C,Ortego M,et al.ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis[J].Am J Pathol,1998,153(6):1825-1837.
7Wang DL,Wung BS,Shyy YJ,et al.Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells.Effects of mechanical strain on monocyte adhesion to endothelial cells[J].Circ Res,1995,77(2):294-302.
8Ruan Q,Deng Z,Song J.Very low density lipoprotein and oxidized very low density lipoprotein induce monocyte chemotactic protein 1 in rabbit aortic smooth muscle cells[J].Chin Med J (Engl),1996,109(3):206-209.
9Torzewski J,Oldroyd R,Lachmann P,et al.Complementinduced release of monocyte chemotactic protein-1 from human smooth muscle cells.A possible initiating event in atherosclerotic lesion formation[J].Arterioscler Thromb Vasc Biol,1996,16(5):673-677.
10Wenzel UO,Fouqueray B,Grandaliano G,et al.Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells[J].Circ Res,1995,77(3):503-509.
